SE399263B - Analogiforfarande for framstellning av triazaspirodekaner med terapeutisk verkan - Google Patents

Analogiforfarande for framstellning av triazaspirodekaner med terapeutisk verkan

Info

Publication number
SE399263B
SE399263B SE7505022A SE7505022A SE399263B SE 399263 B SE399263 B SE 399263B SE 7505022 A SE7505022 A SE 7505022A SE 7505022 A SE7505022 A SE 7505022A SE 399263 B SE399263 B SE 399263B
Authority
SE
Sweden
Prior art keywords
triazaspirodecanes
preparation
therapeutic effect
analogical procedure
analogical
Prior art date
Application number
SE7505022A
Other languages
English (en)
Other versions
SE7505022L (sv
Inventor
I Murayama
M Nakao
K Sasajima
I Yanagihara
S Inaba
H Yamamoto
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of SE7505022L publication Critical patent/SE7505022L/xx
Publication of SE399263B publication Critical patent/SE399263B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/52Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7505022A 1971-08-26 1975-04-29 Analogiforfarande for framstellning av triazaspirodekaner med terapeutisk verkan SE399263B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6564171A JPS5511671B2 (sv) 1971-08-26 1971-08-26

Publications (2)

Publication Number Publication Date
SE7505022L SE7505022L (sv) 1975-04-29
SE399263B true SE399263B (sv) 1978-02-06

Family

ID=13292836

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7210999A SE395892B (sv) 1971-08-26 1972-08-24 Forfarande for framstellning av piperidyl-bensimidazoliner med terapeutisk verkan
SE7505022A SE399263B (sv) 1971-08-26 1975-04-29 Analogiforfarande for framstellning av triazaspirodekaner med terapeutisk verkan

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7210999A SE395892B (sv) 1971-08-26 1972-08-24 Forfarande for framstellning av piperidyl-bensimidazoliner med terapeutisk verkan

Country Status (11)

Country Link
US (1) US3840529A (sv)
JP (1) JPS5511671B2 (sv)
AU (1) AU451875B2 (sv)
BE (1) BE788050A (sv)
CA (1) CA986105A (sv)
CH (1) CH551413A (sv)
DE (1) DE2264668A1 (sv)
FR (1) FR2150880B1 (sv)
GB (1) GB1363195A (sv)
NL (1) NL7211619A (sv)
SE (2) SE395892B (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4080328A (en) * 1971-07-13 1978-03-21 Sumitomo Chemical Company, Limited N-substituted heterocyclic derivatives and preparation thereof
CA1012540A (en) * 1972-06-17 1977-06-21 Sumitomo Chemical Company 2-propanol derivatives and preparation thereof
US3894030A (en) * 1973-01-04 1975-07-08 Janssen Pharmaceutica Nv 1-{8 1-(2-Hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds
AT344695B (de) * 1974-02-28 1978-08-10 Sumitomo Chemical Co Verfahren zur herstellung neuer phenoxypropylaminderivate und ihrer salze
US3989707A (en) * 1974-06-21 1976-11-02 Janssen Pharmaceutica N.V. Benzimidazolinone derivatives
US3996362A (en) * 1975-05-28 1976-12-07 E. R. Squibb & Sons, Inc. 2-[[4-(2,3-Dihydro-2-oxo-1H-benzimidazol-1-yl)-1-(piperidinyl or 1,2,3,6-tetrahydro-1-pyridinyl)]alkyl]-1H-benz[de]isoquinoline-1,3(2H)-diones
JPS6026783B2 (ja) * 1975-06-03 1985-06-25 ウェルファイド株式会社 新規な有機化合物の製造法
US3996363A (en) * 1975-06-13 1976-12-07 E. R. Squibb & Sons, Inc. 2-[(4-Oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)alkyl]-1H-benz[de]isoquinolin-1,3(2H)-diones
JPS58148719U (ja) * 1982-03-26 1983-10-06 赤井電機株式会社 磁気ヘツド
US5032312A (en) * 1989-04-20 1991-07-16 Hoffmann-La Roche Inc. 3E-cyclohexylalkoxy derivatives

Also Published As

Publication number Publication date
BE788050A (fr) 1972-12-18
JPS4832878A (sv) 1973-05-02
JPS5511671B2 (sv) 1980-03-26
AU451875B2 (en) 1974-08-22
AU4594572A (en) 1974-02-28
DE2241566B2 (de) 1975-09-25
SE7505022L (sv) 1975-04-29
SE395892B (sv) 1977-08-29
FR2150880B1 (sv) 1975-10-17
CA986105A (en) 1976-03-23
CH551413A (fr) 1974-07-15
NL7211619A (sv) 1973-02-28
DE2264668A1 (de) 1975-03-20
FR2150880A1 (sv) 1973-04-13
DE2241566A1 (de) 1973-04-19
GB1363195A (en) 1974-08-14
US3840529A (en) 1974-10-08

Similar Documents

Publication Publication Date Title
SE393381B (sv) Analogiforfarande for framstellning av 8-azapurin - 6 - onderivat
SE389670B (sv) Forfarande for framstellning av aroyl-substituerade pyrroler med terapeutisk verkan
SE393800B (sv) Forfarande for framstellning av bensoylamino-alkyl-fenoxi-alkylkarbonsyraderivat med lipidsenkande effekt
NO138807C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivr e 3-merkaptotiadiazol- eller merkaptotetrazol-cefalosporine
SE405599B (sv) Forfarande for framstellning av pyridazinoner med terapeutisk verkan
NO138374C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-fenoksyfenoksyalkankarboksylsyrederivater
SE390304B (sv) Analogiforfarande for framstellning av 4-hydroxi-5-etyl-6-fonylpyrimidin
SE394678B (sv) Analogiforfarande for framstellning av pyridokinolinderivat
SE406197B (sv) Analogiforfarande for framstellning av 4-aminokinazolinderivat
SE411755B (sv) Forfarande for framstellning av n-substituerade 1-aminometylindaner
NO143158C (no) Fremgangsmaate for fremstilling av cefaleksin med forbedret renhet
NO139685C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolin-derivater
SE399263B (sv) Analogiforfarande for framstellning av triazaspirodekaner med terapeutisk verkan
SE402460B (sv) Analogiforfarande for framstellning av alkaloidestrar av eburnamintyp
NO137387C (no) Analogifremgangsm}te til fremstilling av 5-metyltiopyrimidiner med terapeutisk virkning
NO136795C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive indoliner
SE410732B (sv) Analogiforfarande for framstellning av anilidderivat med terapeutisk verkan
SE410596B (sv) Analogiforfarande for framstellning av bensoyl-fenylalanyl-tyrosinderivat med terapeutisk verkan
SE399069B (sv) Analogiforfarande for framstellning av triazolo-pyridino-isokinolin-derivat
FI55988C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara o-acylfenoletanolaminer
SE392722B (sv) Forfarande for framstellning av oxazolidinderivat med terapeutisk verkan
SE7507887L (sv) Forfarande for framstellning av bensopyranforeningar med terapeutisk verkan.
SE385696B (sv) Nytt forfarande for framstellning av n-(1-etyl-alfa-pyrrolidylmetyl)-2-metoxi-5-sulfamidobensamid med terapeutiska egenskaper
SE417206B (sv) Forfarande for framstellning av foreningar med autibiotisk verkan
SE404803B (sv) Analogiforfaranden for framstellning av pyrido-diazepiner